Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   


RGD uses the Human Disease Ontology (DO, for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:von Hippel-Lindau disease
go back to main search page
Accession:DOID:14175 term browser browse the term
Definition:An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.
Synonyms:exact_synonym: Angiomatosis Retinae;   Familial Cerebello Retinal Angiomatosis;   Familial Cerebello-Retinal Angiomatoses;   Familial Cerebelloretinal Angiomatoses;   Familial Cerebelloretinal Angiomatosis;   Hippel Lindau Disease;   Hippel Lindau syndrome;   Lindau Disease;   Lindau's Disease;   Lindau's Diseases;   Lindaus Disease;   VHL;   VHL Syndrome;   VHL Syndromes;   von Hippel Lindau Syndrome;   von Hippel-Lindau
 related_synonym: von Hippel-Lindau syndrome, modifier of;   von Hippel-Lindau syndrome, modifiers of
 primary_id: MESH:D006623
 alt_id: OMIM:193300
 xref: GARD:7855;   ICD10CM:Q85.8;   NCI:C3105
For additional species annotation, visit the Alliance of Genome Resources.

show annotations for term's descendants           Sort by:
von Hippel-Lindau disease term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CCND1 cyclin D1 ISO OMIM NCBI chr18:48,501,905...48,509,684
Ensembl chr18:48,501,899...48,516,005
JBrowse link
G EPAS1 endothelial PAS domain protein 1 ISO protein:increased expression:kidney: RGD PMID:22299048 RGD:11041600 NCBI chr10:48,550,836...48,636,776
Ensembl chr10:48,551,410...48,634,844
JBrowse link
G MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase) onset ISO RGD PMID:19551141 RGD:7241233 NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222
JBrowse link
G SLC18A1 solute carrier family 18 member A1 ISO mRNA:increased expression:tumor (human) RGD PMID:16189177 RGD:5131200 NCBI chr25:36,859,047...36,904,057
Ensembl chr25:36,872,636...36,904,056
JBrowse link
G VHL von Hippel-Lindau tumor suppressor ISO OMIM NCBI chr20:8,206,616...8,211,347
Ensembl chr20:8,206,616...8,211,323
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 12699
    syndrome 6161
      Neurocutaneous Syndromes 147
        von Hippel-Lindau disease 5
Path 2
Term Annotations click to browse term
  disease 12699
    disease of anatomical entity 12239
      nervous system disease 10001
        sensory system disease 4836
          skin disease 2530
            Skin Neoplasms 238
              skin benign neoplasm 67
                skin hemangioma 17
                  capillary hemangioma 15
                    hemangioblastoma 7
                      von Hippel-Lindau disease 5
paths to the root


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.